Trials / Completed
CompletedNCT03565237
RIXUBIS PMS India (RIXUBIS PMS)
Phase IV Multi-Center, Prospective, Interventional, Post-Marketing Study in Hemophilia B Patients in India Receiving RIXUBIS as On-demand or Prophylaxis Under Standard Clinical Practice
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Baxalta now part of Shire · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterize the safety and describe the effectiveness of RIXUBIS in routine clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | RIXUBIS: On-Demand | RIXUBIS used under standard clinical practice in India: On-Demand treatment. |
| BIOLOGICAL | RIXUBIS: Prophylaxis | RIXUBIS used under standard clinical practice in India: Prophylaxis treatment. |
Timeline
- Start date
- 2018-12-07
- Primary completion
- 2021-08-11
- Completion
- 2021-08-11
- First posted
- 2018-06-21
- Last updated
- 2022-08-30
- Results posted
- 2022-08-30
Locations
1 site across 1 country: India
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03565237. Inclusion in this directory is not an endorsement.